We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$151M
AUM Growth
+$10.1M
Cap. Flow
+$16.3M
Cap. Flow %
10.8%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$8.86M
2
KSU
Kansas City Southern
KSU
+$3.59M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$3.54M
4
PPD
PPD, Inc. Common Stock
PPD
+$3.47M
5
FIVN icon
FIVE9
FIVN
+$3.18M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$9.44M
2
MXIM
Maxim Integrated Products
MXIM
+$4.49M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.96M
4
WORK
Slack Technologies, Inc.
WORK
+$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
1
Dell
DELL
$262B
$37M 24.47%
701,291
– –
CPNG icon
2
Coupang
CPNG
$28.9B
$7.14M 4.72%
+256,264
New +$8.86M
MSDAU
3
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$5M 3.31%
500,000
– –
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
$3.82M 2.53%
32,743
– –
XLNX
5
DELISTED
Xilinx Inc
XLNX
$3.65M 2.42%
24,173
– –
NUAN
6
DELISTED
Nuance Communications, Inc.
NUAN
$3.57M 2.36%
64,841
– –
PPD
7
DELISTED
PPD, Inc. Common Stock
PPD
$3.5M 2.32%
+74,900
New +$3.47M
KSU
8
DELISTED
Kansas City Southern
KSU
$3.49M 2.31%
+12,910
New +$3.59M
CHNG
9
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$3.39M 2.25%
+162,100
New +$3.54M
SMIN icon
10
iShares MSCI India Small-Cap ETF
SMIN
$753M
$3.15M 2.08%
52,339
+2,918
+6% +$167K
FIVN icon
11
FIVE9
FIVN
$2.12B
$2.78M 1.84%
+17,400
New +$3.18M
BABA icon
12
Alibaba
BABA
$279B
$2.73M 1.8%
18,419
-7,653
-29% -$1.39M
CPARU
13
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
$1.97M 1.3%
200,000
– –
XLRN
14
DELISTED
Acceleron Pharma
XLRN
$1.68M 1.11%
9,777
+3,600
+58% +$471K
ACRS icon
15
Aclaris Therapeutics
ACRS
$743M
$1.68M 1.11%
93,000
+53,325
+134% +$855K
ONC
16
BeOne Medicines Ltd
ONC
$33.4B
$1.65M 1.09%
4,549
+2,318
+104% +$758K
ASND icon
17
Ascendis Pharma A/S
ASND
$16.5B
$1.56M 1.03%
9,769
+3,709
+61% +$508K
CLDX icon
18
Celldex Therapeutics
CLDX
$3.02B
$1.54M 1.02%
28,466
-5,427
-16% -$255K
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.5M 0.99%
8,489
+3,563
+72% +$573K
ARNA
20
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.42M 0.94%
+23,858
New +$1.41M
KNTE
21
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$1.4M 0.93%
60,905
+27,514
+82% +$599K
RNAM
22
DELISTED
Avidity Biosciences
RNAM
$1.4M 0.93%
+56,852
New +$1.24M
IOVA icon
23
Iovance Biotherapeutics
IOVA
$2.09B
$1.39M 0.92%
56,276
+23,818
+73% +$561K
TVTX icon
24
Travere Therapeutics
TVTX
$5.33B
$1.38M 0.91%
56,694
+3,196
+6% +$58.7K
ZNTL icon
25
Zentalis Pharmaceuticals
ZNTL
$350M
$1.37M 0.91%
+20,596
New +$1.19M
1
2 3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

HighVista Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, HighVista Strategies held 155 positions worth $151M, up 7.2% from $141M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HighVista Strategies deployed $16.3M of net new capital in Q3 2021, opening 39 new positions and adding to 47 existing holdings. Its largest new stake was Coupang: 256,264 shares worth $7.14M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $1.39M trimmed.

  • HighVista Strategies's largest Q3 2021 buy was Coupang: 256,264 shares worth $7.14M.
  • HighVista Strategies added most to ESSA Pharma in Q3 2021, an estimated $1.9M increase.
  • HighVista Strategies's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.39M.
  • HighVista Strategies fully exited Willis Towers Watson in Q3 2021, selling an estimated $9.44M.
  • HighVista Strategies's ten largest holdings make up 49% of its $151M portfolio in Q3 2021.
  • HighVista Strategies opened 39 new positions and closed 28 in Q3 2021.
  • HighVista Strategies's portfolio value rose 7.2% quarter-over-quarter to $151M.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.